1. Brook RD, Rajagopalan S, Pope CA 3rd, et al. Particulate matterair pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association. Circulation. 2010; 121:2331–2378.
2. Atkinson RW, Anderson HR, Sunyer J, et al. Acute effects of particulate air pollution on respiratory admissions: results from APHEA 2 project. Air Pollution and Health: a European Approach. Am J Respir Crit Care Med. 2001; 164(10 Pt 1):1860–1866.
3. Samoli E, Analitis A, Touloumi G, et al. Estimating the exposure-response relationships between particulate matter and mortality within the APHEA multicity project. Environ Health Perspect. 2005; 113:88–95.
Article
4. Novaes P, Saldiva PH, Matsuda M, et al. The effects of chronic exposure to traffic derived air pollution on the ocular surface. Environ Res. 2010; 110:372–374.
Article
5. Malerbi FK, Martins LC, Saldiva PH, Braga AL. Ambient levels of air pollution induce clinical worsening of blepharitis. Environ Res. 2012; 112:199–203.
Article
6. Galor A, Kumar N, Feuer W, Lee DJ. Environmental factors affect the risk of dry eye syndrome in a United States veteran population. Ophthalmology. 2014; 121:972–973.
Article
7. Eisenbarth SC, Flavell RA. Innate instruction of adaptive immunity revisited: the inflammasome. EMBO Mol Med. 2009; 1:92–98.
Article
8. He Y, Hara H, Núñez G. Mechanism and regulation of NLRP3 inflammasome activation. Trends Biochem Sci. 2016; 41:1012–1021.
Article
9. Jo EK, Kim JK, Shin DM, Sasakawa C. Molecular mechanisms regulating NLRP3 inflammasome activation. Cell Mol Immunol. 2016; 13:148–159.
Article
10. Zheng Q, Ren Y, Reinach PS, et al. Reactive oxygen species activated NLRP3 inflammasomes prime environment-induced murine dry eye. Exp Eye Res. 2014; 125:1–8.
Article
11. Zheng Q, Ren Y, Reinach PS, et al. Reactive oxygen species activated NLRP3 inflammasomes initiate inflammation in hyperosmolarity stressed human corneal epithelial cells and environment-induced dry eye patients. Exp Eye Res. 2015; 134:133–140.
Article
12. Warheit DB, Sayes CM, Reed KL, Swain KA. Health effects related to nanoparticle exposures: environmental, health and safety considerations for assessing hazards and risks. Pharmacol Ther. 2008; 120:35–42.
Article
13. Sun Q, Tan D, Ze Y, et al. Pulmotoxicological effects caused by long-term titanium dioxide nanoparticles exposure in mice. J Hazard Mater. 2012; 235-236:47–53.
Article
14. Chang X, Fu Y, Zhang Y, et al. Effects of Th1 and Th2 cells balance in pulmonary injury induced by nano titanium dioxide. Environ Toxicol Pharmacol. 2014; 37:275–283.
Article
15. Hong J, Wang L, Zhao X, et al. Th2 factors may be involved in TiO2 NP-induced hepatic inflammation. J Agric Food Chem. 2014; 62:6871–6878.
Article
16. Eom Y, Song JS, Lee DY, et al. Effect of titanium dioxide nanoparticle exposure on the ocular surface: an animal study. Ocul Surf. 2016; 14:224–232.
Article
17. Eom Y, Song JS, Lee HK, et al. The effect of ambient titanium dioxide microparticle exposure to the ocular surface on the expression of inflammatory cytokines in the eye and cervical lymph nodes. Invest Ophthalmol Vis Sci. 2016; 57:6580–6590.
Article
18. Han JY, Kang B, Eom Y, et al. Comparing the effects of particulate matter on the ocular surfaces of normal eyes and a dry eye rat model. Cornea. 2017; 36:605–610.
Article
19. The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007; 5:93–107.
20. Stapleton F, Alves M, Bunya VY, et al. TFOS DEWS II Epidemiology Report. Ocul Surf. 2017; 15:334–365.
Article